C-Path leads collaborations that accelerate drug development, advancing better treatment for people worldwide. The Critical Path Institute (C-Path) is an independent, non-profit organization established in 2005. Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDAs Critical Path Initiative. C-Path's mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path's global headquarters is in Tucson, Arizona and C-Paths Europe subsidiary is headquartered in Amsterdam, Netherlands.